China-Norway Patent Prosecution Highway (PPH) Pilot to Start April 1, 2020

Posted on Categories New Law, Rule or Implementing Regulation, Patents

In an announcement by the China National Intellectual Property Administration (CNIPA), a memorandum of understanding has been signed between the CNIPA and the Norwegian Industrial Property Office (NIPO) allowing for accelerated examination of patent applications in each jurisdiction.  The pilot will start April 1, 2020 and extend for three years to March 31, 2023.

Patents Required to List on the Shanghai Stock Exchange’s Science & Technology Board

Posted on Categories New Law, Rule or Implementing Regulation, Patents

On March 20, 2020, the Chinese Securities Regulatory Commission (similar to the Securities and Exchange Commission in the U.S.) released the Science and Technology Attribute Evaluation Guidelines (Trial) stating requirements to list on the Shanghai Stock Exchange’s Science & Technology Board.  Among other requirements, applicants to list must have Chinese invention patents.

China Waives Late Fees for Missed Patent Annuities due to Coronavirus

Posted on Categories New Law, Rule or Implementing Regulation, Patents

The China National Intellectual Property Administration (CNIPA) announced on March 4, 2020 that late fees for missed patent annuity payments will be waived if caused by the coronavirus epidemic. This expands on Bureau Announcement 350, which explained that patentees and applicants can restore their patent rights without payment of a restoration right request fee if lost rights were due to the coronavirus.

Chinese Trademark Office Cracks Down on Malicious Filing of Coronavirus-Related Trademarks

Posted on Categories New Law, Rule or Implementing Regulation, Trademarks

In a notice dated February 27, 2020, the Chinese Trademark Office announced issuance of the Guidelines for the Examination of Epidemic Prevention and Control-Related Trademarks, which provides guidance on the examination of marks for the names of people involved in the epidemic, marks  related to the epidemic virus and disease, marks related to epidemic-related drugs, marks for  protective products (e.g., respirators), and other marks related to the epidemic.